SLC4A7 and cancer: The cell surface expression makes NBCn1 readily available for extracellular binding; and the up to 7-fold upregulation of NBCn1 protein expression from normal breast tissue across pre-malignant tissue to full-blown cancer tissue supports therapeutic specificity [27].